Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

OPEN-LABEL

Clinical trials for OPEN-LABEL explained in plain language.

Never miss a new study

Get alerted when new OPEN-LABEL trials appear

Sign up with your email to follow new studies for OPEN-LABEL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1
Sort by
  • New drug combo targets tough cancers in early trial

    Disease control Recruiting now

    This early-stage study tests a new oral drug, FX-909, alone or with another drug (pembrolizumab) in people with advanced solid tumors, including a type of bladder cancer. The main goals are to check safety and find the best dose. About 120 adults will take part, taking daily pill…

    Matched conditions: OPEN-LABEL

    Phase: PHASE1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control

    Last updated Jun 27, 2026 12:10 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space